Cerus, Baxter Healthcare Corp. deal

The companies amended their funding commitments and revenue sharing for their 1993 and 1996 deals to develop pathogen inactivation systems for platelets, red

Read the full 236 word article

How to gain access

Continue reading with a
two-week free trial.